Class II
Ongoing
Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
Why: Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.
- Company
- Pfizer
Manhattan, NY, United States - Reported
- Oct 28, 2026
- Recall started
- Sep 29, 2026
- Where sold
- US Nationwide and Puerto Rico
- Amount
- 15,815 100-count bottles
- Full product description
- Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-01.
- Lots / codes affected
- Lot # 24W06, Exp: 11/30/2026
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.